Recruiting OBSERVATIONAL NCT05259605

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Choroid Plexus Tumor Diffuse Midline Glioma, H3 K27M-Mutant Embryonal Tumor Ependymoma Germ Cell Tumor Glioma Glioneuronal Tumor Hemangioblastoma Hemangiopericytoma Melanocytic Tumor of CNS Pineal Tumor Pineal Tumors Tumor of the Sellar Region

Interventions Observational

Updated 9 times since 2022 Last updated: Dec 11, 2025 Started: Mar 21, 2023 Primary completion: Dec 30, 2027 Completion: Jul 29, 2038

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05259605, this observational or N/A phase trial focuses on Choroid Plexus Tumor and Diffuse Midline Glioma, H3 K27M-Mutant and remains actively recruiting participants. Sponsored by European Organisation for Research and Treatment of Cancer - EORTC, it has been updated 9 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Recruiting
Sep 2025 — Jan 2026 [monthly]

Recruiting
Feb 2025 — Sep 2025 [monthly]

Recruiting
Dec 2024 — Feb 2025 [monthly]

Recruiting
Sep 2024 — Dec 2024 [monthly]

Recruiting

▶ Show 4 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Apr 2023 [monthly]

Not Yet Recruiting
Mar 2022 — Sep 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalst, Belgium , Amsterdam, Netherlands , Anderlecht, Belgium , Athens, Greece , Barcelona, Spain , Bochum, Germany , Bologna, Italy , Bonn, Germany , Brussels, Belgium , Cologne, Germany and 27 more locations